An Open-Label Study of Adjunctive Dextromethorphan/Quinidine in Treatment-Resistant Depression.

Wang, Philip R; Yavi, Mani; Lee, Holim; Kotb, Yasmine; Shora, Lorie; Park, Lawrence T; Zarate, Carlos A

Wang, Philip R; Yavi, Mani; Lee, Holim; Kotb, Yasmine; Shora, Lorie; Park, Lawrence T; Zarate, Carlos A.

Affiliation

Wang PR; From the Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, Bethesda, MD.

J Clin Psychopharmacol ; 43(5): 422-427, 2023.

Article in En | MEDLINE | ID: mdl-37683231

Subject(s)

Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Male; Female; Humans; Quinidine/adverse effects; Dextromethorphan/pharmacology; Depressive Disorder, Major/drug therapy; Treatment Outcome; Depression; Pilot Projects; Antidepressive Agents/adverse effects; Depressive Disorder, Treatment-Resistant/drug therapy; Double-Blind Method

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Depressive Disorder, Major / Depressive Disorder, Treatment-Resistant Type of study: Clinical_trials Limits: Female / Humans / Male Language: En Journal: J Clin Psychopharmacol Year: 2023 Document type: Article Affiliation country: Moldova

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google